96 related articles for article (PubMed ID: 31281496)
21. E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies.
Zhou Z; Zheng K; Zhou S; Yang Y; Chen J; Jin X
J Mol Med (Berl); 2023 Dec; 101(12):1543-1565. PubMed ID: 37796337
[TBL] [Abstract][Full Text] [Related]
22. FAM3A reshapes VSMC fate specification in abdominal aortic aneurysm by regulating KLF4 ubiquitination.
Lei C; Kan H; Xian X; Chen W; Xiang W; Song X; Wu J; Yang D; Zheng Y
Nat Commun; 2023 Sep; 14(1):5360. PubMed ID: 37660071
[TBL] [Abstract][Full Text] [Related]
23. Role of K63-linked ubiquitination in cancer.
Cao L; Liu X; Zheng B; Xing C; Liu J
Cell Death Discov; 2022 Oct; 8(1):410. PubMed ID: 36202787
[TBL] [Abstract][Full Text] [Related]
24. Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.
Yin X; Liu Q; Liu F; Tian X; Yan T; Han J; Jiang S
Front Cell Dev Biol; 2022; 10():944460. PubMed ID: 35874839
[TBL] [Abstract][Full Text] [Related]
25. shRNA targeting PLK1 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells.
Zhou Y; Wu C; Liu B; Zhu J; Zhong Y; Yuan Y; Huang Y; Tang Y
Transl Cancer Res; 2020 Sep; 9(9):5350-5359. PubMed ID: 35117900
[TBL] [Abstract][Full Text] [Related]
26. Modulation of IL-6 Expression by KLF4-Mediated Transactivation and PCAF-Mediated Acetylation in Sublytic C5b-9-Induced Rat Glomerular Mesangial Cells.
Xia L; Liu Y; Zhang Z; Gong Y; Yu T; Zhao D; Qiu W; Wang Y; Zhang J
Front Immunol; 2021; 12():779667. PubMed ID: 35046941
[TBL] [Abstract][Full Text] [Related]
27. Incomplete thermal ablation-induced up-regulation of transcription factor nuclear receptor subfamily 2, group F, member 6 (NR2F6) contributes to the rapid progression of residual liver tumor in hepatoblastoma.
Pang JS; Wen DY; He RQ; Chen G; Lin P; Li JH; Zhao YJ; Wu LY; Chen JH; He Y; Qin LT; Chen JB; Li Y; Yang H
Bioengineered; 2021 Dec; 12(1):4289-4303. PubMed ID: 34304715
[TBL] [Abstract][Full Text] [Related]
28. Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis.
Islam Z; Ali AM; Naik A; Eldaw M; Decock J; Kolatkar PR
Front Oncol; 2021; 11():681377. PubMed ID: 34195082
[TBL] [Abstract][Full Text] [Related]
29. Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation.
Zhu H; Li Q; Zhao Y; Peng H; Guo L; Zhu J; Jiang Z; Zeng Z; Xu B; Chen S
Oncogene; 2021 Jul; 40(28):4663-4674. PubMed ID: 34140642
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway.
Zhao S; Geng Y; Cao L; Yang Q; Pan T; Zhou D; Liu J; Shi Z; Zhang J
Am J Cancer Res; 2021; 11(5):2142-2158. PubMed ID: 34094674
[TBL] [Abstract][Full Text] [Related]
31. Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion.
Ding J; Zhang Y; Cai X; Zhang Y; Yan S; Wang J; Zhang S; Yin T; Yang C; Yang J
Theranostics; 2021; 11(12):5813-5830. PubMed ID: 33897883
[No Abstract] [Full Text] [Related]
32. AKT-mediated regulation of chromatin ubiquitylation and tumorigenesis through Mel18 phosphorylation.
Mai J; Peng XD; Tang J; Du T; Chen YH; Wang ZF; Zhang HL; Huang JH; Zhong ZY; Yang D; Li ZL; Huang Y; Feng GK; Zhu XF; Deng R
Oncogene; 2021 Apr; 40(13):2422-2436. PubMed ID: 33664452
[TBL] [Abstract][Full Text] [Related]
33. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
Zhang C; Wang X; Fang D; Xu P; Mo X; Hu C; Abdelatty A; Wang M; Xu H; Sun Q; Zhou G; She J; Xia J; Hui KM; Xia H
Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
[No Abstract] [Full Text] [Related]
34. Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.
Cao Y; Xie L; Shi F; Tang M; Li Y; Hu J; Zhao L; Zhao L; Yu X; Luo X; Liao W; Bode AM
Signal Transduct Target Ther; 2021 Jan; 6(1):15. PubMed ID: 33436584
[TBL] [Abstract][Full Text] [Related]
35. MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Deng R; Zhang HL; Huang JH; Cai RZ; Wang Y; Chen YH; Hu BX; Ye ZP; Li ZL; Mai J; Huang Y; Li X; Peng XD; Feng GK; Li JD; Tang J; Zhu XF
Autophagy; 2021 Oct; 17(10):3011-3029. PubMed ID: 33213267
[TBL] [Abstract][Full Text] [Related]
36. Impact of KLF4 on Cell Proliferation and Epithelial Differentiation in the Context of Cystic Fibrosis.
Sousa L; Pankonien I; Simões FB; Chanson M; Amaral MD
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937756
[TBL] [Abstract][Full Text] [Related]
37. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
38. PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β-catenin signalling pathway.
Chen Y; Chen X; Ji YR; Zhu S; Bu FT; Du XS; Meng XM; Huang C; Li J
J Cell Mol Med; 2020 Jul; 24(13):7405-7416. PubMed ID: 32463161
[TBL] [Abstract][Full Text] [Related]
39. Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma.
Mai J; Zhong ZY; Guo GF; Chen XX; Xiang YQ; Li X; Zhang HL; Chen YH; Xu XL; Wu RY; Yu Y; Li ZL; Peng XD; Huang Y; Zhou LH; Feng GK; Guo X; Deng R; Zhu XF
Theranostics; 2019; 9(12):3541-3554. PubMed ID: 31281496
[No Abstract] [Full Text] [Related]
40. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
